pubmed-article:21311184 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:21311184 | lifeskim:mentions | umls-concept:C0001617 | lld:lifeskim |
pubmed-article:21311184 | lifeskim:mentions | umls-concept:C0343192 | lld:lifeskim |
pubmed-article:21311184 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:21311184 | lifeskim:mentions | umls-concept:C0209368 | lld:lifeskim |
pubmed-article:21311184 | lifeskim:mentions | umls-concept:C0600558 | lld:lifeskim |
pubmed-article:21311184 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
pubmed-article:21311184 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:21311184 | pubmed:dateCreated | 2011-3-4 | lld:pubmed |
pubmed-article:21311184 | pubmed:abstractText | We prospectively compared the effects of oral mycophenolate mofetil (MMF) or intravenous cyclophosphamide (IVC) combined with corticosteroids for induction therapy of microscopic polyangiitis (MPA) with renal involvement over a follow-up period of 6 months. | lld:pubmed |
pubmed-article:21311184 | pubmed:language | eng | lld:pubmed |
pubmed-article:21311184 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21311184 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:21311184 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21311184 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21311184 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21311184 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21311184 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:21311184 | pubmed:issn | 1421-9670 | lld:pubmed |
pubmed-article:21311184 | pubmed:author | pubmed-author:IuSS | lld:pubmed |
pubmed-article:21311184 | pubmed:author | pubmed-author:LiQunQ | lld:pubmed |
pubmed-article:21311184 | pubmed:author | pubmed-author:ZhangXiaohuiX | lld:pubmed |
pubmed-article:21311184 | pubmed:author | pubmed-author:HeQiangQ | lld:pubmed |
pubmed-article:21311184 | pubmed:author | pubmed-author:WangHuipingH | lld:pubmed |
pubmed-article:21311184 | pubmed:author | pubmed-author:QiXiangX | lld:pubmed |
pubmed-article:21311184 | pubmed:author | pubmed-author:ChenJianghuaJ | lld:pubmed |
pubmed-article:21311184 | pubmed:author | pubmed-author:WangSuyaS | lld:pubmed |
pubmed-article:21311184 | pubmed:author | pubmed-author:LiuGuangyiG | lld:pubmed |
pubmed-article:21311184 | pubmed:author | pubmed-author:HeXuelinX | lld:pubmed |
pubmed-article:21311184 | pubmed:copyrightInfo | Copyright © 2011 S. Karger AG, Basel. | lld:pubmed |
pubmed-article:21311184 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:21311184 | pubmed:volume | 33 | lld:pubmed |
pubmed-article:21311184 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:21311184 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:21311184 | pubmed:pagination | 185-92 | lld:pubmed |
pubmed-article:21311184 | pubmed:meshHeading | pubmed-meshheading:21311184... | lld:pubmed |
pubmed-article:21311184 | pubmed:meshHeading | pubmed-meshheading:21311184... | lld:pubmed |
pubmed-article:21311184 | pubmed:meshHeading | pubmed-meshheading:21311184... | lld:pubmed |
pubmed-article:21311184 | pubmed:meshHeading | pubmed-meshheading:21311184... | lld:pubmed |
pubmed-article:21311184 | pubmed:meshHeading | pubmed-meshheading:21311184... | lld:pubmed |
pubmed-article:21311184 | pubmed:meshHeading | pubmed-meshheading:21311184... | lld:pubmed |
pubmed-article:21311184 | pubmed:meshHeading | pubmed-meshheading:21311184... | lld:pubmed |
pubmed-article:21311184 | pubmed:meshHeading | pubmed-meshheading:21311184... | lld:pubmed |
pubmed-article:21311184 | pubmed:meshHeading | pubmed-meshheading:21311184... | lld:pubmed |
pubmed-article:21311184 | pubmed:meshHeading | pubmed-meshheading:21311184... | lld:pubmed |
pubmed-article:21311184 | pubmed:meshHeading | pubmed-meshheading:21311184... | lld:pubmed |
pubmed-article:21311184 | pubmed:meshHeading | pubmed-meshheading:21311184... | lld:pubmed |
pubmed-article:21311184 | pubmed:meshHeading | pubmed-meshheading:21311184... | lld:pubmed |
pubmed-article:21311184 | pubmed:meshHeading | pubmed-meshheading:21311184... | lld:pubmed |
pubmed-article:21311184 | pubmed:meshHeading | pubmed-meshheading:21311184... | lld:pubmed |
pubmed-article:21311184 | pubmed:meshHeading | pubmed-meshheading:21311184... | lld:pubmed |
pubmed-article:21311184 | pubmed:meshHeading | pubmed-meshheading:21311184... | lld:pubmed |
pubmed-article:21311184 | pubmed:meshHeading | pubmed-meshheading:21311184... | lld:pubmed |
pubmed-article:21311184 | pubmed:year | 2011 | lld:pubmed |
pubmed-article:21311184 | pubmed:articleTitle | Effects of mycophenolate mofetil combined with corticosteroids for induction therapy of microscopic polyangiitis. | lld:pubmed |
pubmed-article:21311184 | pubmed:affiliation | Kidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, PR China. | lld:pubmed |
pubmed-article:21311184 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:21311184 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:21311184 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |